Literatura académica sobre el tema "Diabète – chirurgie"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Diabète – chirurgie".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Diabète – chirurgie"
Caiazzo, R., L. Arnalsteen y F. Pattou. "De la chirurgie de l’obésité à la chirurgie du diabète". Obésité 5, n.º 4 (22 de noviembre de 2010): 136–39. http://dx.doi.org/10.1007/s11690-010-0247-4.
Texto completoCazeau, Cyrille y Jocelyne MBemba. "Diabète et chirurgie percutanée du pied". Revue du Podologue 14, n.º 83 (septiembre de 2018): 12–15. http://dx.doi.org/10.1016/j.revpod.2018.06.002.
Texto completoAmouyal, C. y F. Andreelli. "Chirurgie métabolique du diabète de type 2". Médecine des Maladies Métaboliques 9, n.º 5 (julio de 2015): 473–81. http://dx.doi.org/10.1016/s1957-2557(15)30200-5.
Texto completoJaffiol, Claude y Patrick Ritz. "Chirurgie métabolique et diabète de type 2". Bulletin de l'Académie Nationale de Médecine 196, n.º 7 (octubre de 2012): 1473–75. http://dx.doi.org/10.1016/s0001-4079(19)31729-7.
Texto completoManus, Jean-Marie. "Brèves : Chirurgie bariatrique et rémission du diabète". Revue Francophone des Laboratoires 2020, n.º 519 (febrero de 2020): 13. http://dx.doi.org/10.1016/s1773-035x(20)30045-9.
Texto completoCiangura, C., M. Coupaye, P. Deruelle, G. Gascoin, D. Calabrese, E. Cosson, G. Ducarme et al. "Grossesses après chirurgie bariatrique : recommandations pour la pratique clinique". Obésité 14, n.º 4 (diciembre de 2019): 163–77. http://dx.doi.org/10.3166/obe-2019-0085.
Texto completoGiusti, Vittorio. "[b]Chirurgie[/b] du diabète : provocation ou réalité ?" Revue Médicale Suisse 6, n.º 242 (2010): 670–76. http://dx.doi.org/10.53738/revmed.2010.6.242.0670.
Texto completoD, Y. M. "Chirurgie bariatrique : un traitement du diabète de type 2". Option/Bio 25, n.º 518 (diciembre de 2014): 10. http://dx.doi.org/10.1016/s0992-5945(14)72015-x.
Texto completoJean-Marie, Manus. "Chirurgie bariatrique, un traitement du diabète de type 2". Revue Francophone des Laboratoires 2024, n.º 563 (2024): 13. http://dx.doi.org/10.1016/s1773-035x(24)76112-7.
Texto completoMithieux, Gilles. "La néoglucogenèse intestinale : une fonction insulinomimétique". Biologie Aujourd’hui 216, n.º 1-2 (2022): 37–39. http://dx.doi.org/10.1051/jbio/2022003.
Texto completoTesis sobre el tema "Diabète – chirurgie"
Maanaoui, Mehdi. "La greffe d'îlots pancréatiques chez le patient diabétique transplanté rénal". Electronic Thesis or Diss., Université de Lille (2022-....), 2023. https://pepite-depot.univ-lille.fr/ToutIDP/EDBSL/2023/2023ULILS071.pdf.
Texto completoPancreatic islet transplantation is an innovative cellular therapy for the management of diabetes in patients with type 1 diabetes. Currently, there are few studies that address the prognostic impact of islet transplantation in patients with type 1 diabetes who have received a kidney transplant or the determinants of transplantation success in this population. Furthermore, the definition of diabetes is evolving, with the dichotomy between type 1 and type 2 diabetes fading in favor of diabetes classifications based on the patient's clinical and biological phenotype. Pancreatic islet transplantation could potentially be expanded to other profiles of patients with diabetes and a kidney transplant, especially if there's evidence of insulin secretion deficiency. Thus, the objective of this thesis is to determine the role of pancreatic islet transplantation in patients with diabetes and a kidney transplant.In the first section, we present the results of a nationwide cohort study assessing the effect of pancreatic islet transplantation following kidney transplantation compared to insulin alone in patients with type 1 diabetes. Islet-after-kidney recipients were matched to control patients using a time-dependent propensity score. After matching, pancreatic islet transplantation is associated with a reduction in the combined risk of death and return to dialysis, as well as the isolated risk of death. This study emphasizes the importance of considering islet transplantation as a full-fledged therapeutic alternative, especially in regions where it is not reimbursed or available.The second section explores the determinants of islet loss of functionality, in particular the repercussions of alloimmunity. The results of a single-center study suggest that preformed DSA and early de novo DSA have little impact on islet transplantation outcomes, but late de novo DSA is temporally associated with impaired metabolic results. No cases of cross-sensitization between pancreatic islets and the underlying kidney in recipients were described, neither in the study nor in the literature.The last section focuses on evaluating the insulin profile in patients with type 2 diabetes and a kidney transplant, through the calculation of HOMA-2 scores, to extract the impact of insulin secretion. Analysis of a single-center retrospective cohort shows an association between insulin resistance evaluated by HOMA-2 and the risk of allograft loss, while insulin secretion was only associated with metabolic balance. However, given the relationship between metabolic balance and the likelihood of death and graft loss in kidney transplant patients with diabetes, pancreatic islet transplantation could be part of the therapeutic arsenal in a personalized medicine approach for these patients.In conclusion, this thesis advocates for personalized diabetes medicine in kidney transplant patients, promoting the integration of pancreatic islet transplantation as a key component in the therapeutic strategy for these individuals
Rouyer, Olivier. "Dysfonctions endothéliales après transplantation et diabète : Approches expérimentales et cliniques". Strasbourg 1, 2008. http://www.theses.fr/2008STR13075.
Texto completoAmong its many functions, vascular endothelium modulates vascular tone by secreting vasodilators and vasoconstrictors factors. Some diseases alter this balance, causing endothelial dysfunction which reduces organ perfusion and may jeopardizing the life. The work presented shows the interest of exploring endothelial dysfunction through endothelium-dependent relaxation studies, both in vitro through the analysis of aortic vascular ring reactivity in chamber organ and in vivo through flow-dependent dilatation of the humeral artery measurement, in response to a post-ischemic hyperaemia. In a model of aged rats with type 1 diabetes induced by streptozotocin, the late introduction of an IEC is deleterious on the exercise capacity. The normalization of blood pressure induced by the IEC could affect muscle perfusion. Endothelial function was not impaired and was not affected when the term of diabetes was lower. In a genetic model of Goto-Kakizaki rat type 2 diabetes, there was endothelial dysfunction related to the production of vasoconstrictors prostanoids. It was not improved by training even if training improved glycemic profile. In stable heart transplant patients with “normal” cardiac function, the persistent rise of plasma BNP values appeared to be related to endothelial dysfunction. While among hepatic transplant patients, normality of the endothelial function could be linked to the low prevalence of cardiovascular risk factors and a possible direct protective effect of Tacrolimus
Plourde, Charles-Étienne. "Les mécanismes de résolutions du diabète de type 2 induits par la chirurgie bariatrique". Mémoire, Université de Sherbrooke, 2015. http://hdl.handle.net/11143/6038.
Texto completoCaiazzo, Robert. "Thérapie cellulaire du diabète : facteurs influençant la fonction primaire du greffon". Lille 2, 2009. http://www.theses.fr/2009LIL2S047.
Texto completoArapis, Konstantinos. "Mise au point de modèles précliniques de chirurgie bariatrique chez le rat rendu obèse par un régime hyperlipidique". Sorbonne Paris Cité, 2015. http://www.theses.fr/2015USPCC086.
Texto completoFavennec, Marie. "Etude de la voie des kynurénines dans l'obésité humaine". Thesis, Lille 2, 2015. http://www.theses.fr/2015LIL2S037/document.
Texto completoTryptophan, an essential amino acid, is either used in protein synthesis or metabolized via the serotonin or the kynurenine pathway. The kynurenine pathway is the main route of tryptophan degradation and generates several metabolites collectively called “kynurenines”. The expression of kynurenine pathway enzymes is induced by inflammatory mediators. Consequently kynurenine synthesis could be induced in individuals with obesity. In fact, obesity is characterized by a chronic low grade inflammation of the adipose tissue reflected by increased serum levels of inflammatory factors which are known to contribute to the development of obesity-induced insulino-resistance. Some metabolites of the kynurenine pathway have been proposed to be risk factors for the development of insulin resistance. Bariatric surgery is currently the most effective treatment for severe obesity and results in a significant weight loss, a decreased level of inflammatory factors and an amelioration of glucose homeostasis. The first enzyme of the kynurenine pathway, IDO1, is known to be more expressed in the adipose tissue of individuals with obesity compared to lean individuals. The kynurenine over tryptophan ratio reflects the activity of IDO1 and is also increased in individuals with obesity.Our objective was to characterize the expression of the kynurenine pathway enzymes in the adipose tissue of women with severe obesity and to evaluate serum levels of the kynurenine pathway metabolites to determine whether these factors could be associated with the appearance of diabetes. This study was performed in women with severe obesity with or without type 2 diabetes. Then we investigated the consequences of weight loss induced by bariatric surgery on levels of circulating kynurenines in order to evaluate whether these variations could explain the improvement in glucose control and type 2 diabetes remission after one year follow-up.In this study, we have shown that several kynurenine pathway enzymes were more expressed in the adipose tissue of women with obesity compared to lean controls. This increase is due to the presence of pro-inflammatory macrophages in the adipose tissue and also comes from the adipocyte response to inflammatory stimuli. In addition, we observed that the serum level of kynurenine and kynurenine over tryptophan ratio are higher in women with higher BMI and they both decrease one year after bariatric surgery. In addition, we observed that the serum level of kynurenine and kynurenine over tryptophan ratio are higher in women with higher BMI and they both decrease one year after bariatric surgery. As expected, bariatric surgery is associated with the improvement and even the remission of type 2 diabetes. We have shown that higher levels of kynurenic acid and quinolinic acid one year after the surgery are associated respectively with type 2 diabetes remission and better glucose homeostasis and that lower levels of xanthurenic acid are associated with better glucose homeostasis
Chavez, Talavera Oscar Manuel. "Rôle des acides biliaires dans la physiopathologie de l'obésité, la résistance à l'insuline, le diabète de type 2, la stéatose hépatique non alcoolique et dans le contexte de la chirurgie bariatrique Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease Bile Acid Alterations in Nonalcoholic Fatty Liver Disease, Obesity, Insulin Resistance and Type 2 Diabetes: What Do the Human Studies Tell?” Bile acids associate with glucose metabolism, but do not predict conversion to diabetes Bile acid alterations are associated with insulin resistance, but not with NASH in obese subjects Roux-en-Y gastric bypass increases systemic but not portal bile acid concentrations by decreasing hepatic bile acid uptake in minipigs The functional relevance of bile acids in the improvement of HDL-mediated endothelial protection after bariatric surgery Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors". Thesis, Lille, 2019. http://www.theses.fr/2019LILUS057.
Texto completoIn addition to their role in the solubilization of dietary lipids, bile acids are signaling molecules regulating their own metabolism, glucose and lipid homeostasis, energy expenditure, cardiovascular function and inflammation via the activation of the Farnesoid X Receptor (FXR) and the Takeda G protein coupled Receptor 5 (TGR5). Indeed, changes in bile acid concentrations are associated with metabolic diseases and therefore they are candidates to participate in the pathophysiology of these diseases or predict their progression.In the first part of this thesis, we studied bile acid changes in the context of obesity, insulin resistance, type 2 diabetes and non-alcoholic steatohepatitis. We demonstrated that bile acids are correlated with glucose homeostasis in humans, but that they are not predictors for the progression from prediabetes to type 2 diabetes in a longitudinal cohort study.In the second part of this thesis, we studied the bile acids in the context of bariatric surgery. Our results showed that bariatric surgery reduces the hepatic recapture of certain bile acids, causing them to increase in the systemic circulation. Additionally, we showed that it is not the bile limb but the common limb the one responsible for metabolic changes after bariatric surgery in the minipig. Finally, we showed in humans that bile acids linked to high-density lipoproteins (HDL) increase after bariatric surgery, and that this increase is correlated with the restoration of their vasoprotective functions
Goncalves, Daisy. "Biodisponibilité de la bile et effets bénéfiques des chirurgies bariatriques de type by-pass". Thesis, Lyon 1, 2014. http://www.theses.fr/2014LYO10171/document.
Texto completoGastric bypass procedures have emerged as an effective treatment for morbid obese diabetic patientssince they provoke a rapid remission of diabetes before any weight loss has occurred. Patients also report adisinterest in high calorie food. A suggested mechanism associated a decrease in hepatic glucose production toan enhanced intestinal gluconeogenesis. Bile acids, described as inhibitors of gluconeogenesis, see theirbioavailability changed after these procedures. Indeed, they are absent in the alimentary limb while theirplasmatic concentration is increased. We therefore tested the hypothesis that plasma bile acids may inhibithepatic glucose production while their absence in the gut could induce intestinal gluconeogenesis.For this, we performed bile diversions matching the modified biliary flow occurring after gastric bypassprocedures. We showed that bile diversions lead to an increase in plasma bile acids. Bile diversions promote ablunting in hepatic glucose production whereas intestinal gluconeogenesis is increased in gut segments devoidof bile. Moreover, the modification of bile routing per se improves glucose control and dramatically decreasefood intake due to an acquired disinterest in fatty food. This data shows that bile routing modification is a keymechanistic feature in the beneficial outcomes of gastric bypass procedures
Amouyal, Chloé. "Restaurer la fonction bêta pancréatique de la souris leptine déficiente par la chirurgie bariatrique". Thesis, Sorbonne université, 2019. http://www.theses.fr/2019SORUS010.
Texto completoEGA (entero-gastro-anastomosis) is a gastric bypass procedure adapted to rodent. EGA in leptin deficient ob/ob mice improves glucose tolerance by increasing pancreatic insulin content and glucose stimulated insulin secretion in vivo without persistent body weight loss dietary restriction, modification of body composition / energy expenditure. We do not observe differences in islets ‘number or size after EGA. Insulin gene expression, beta-cell proliferation (Ki67 index) and insular immune infiltration are also unchanged. Transcriptomic analysis of pancreatic islets showed that bariatric surgery differentially regulated 193 genes and 27 miRs. Interestingly, the surgery normalized molecular defects (down regulation of TRPM5, GLUT2, GCK, connexin 36) and functional alteration (high sensitivity of islets to low glucose levels) observed in diabetic ob pancreatic islets. In addition, the surgery promoted the enrichment of 227 biological process, composed of genes with known or undetermined beta cell function, especially 21 genes are involved in the hormone transport and 20 genes in the hormone secretion biological process. Computational analysis predicted that 7 of 27 miRs (324-3p, 380-3p, 671-5p, 1927, 6904-5p, 6918-5p and 7682-3p) are hubs in the miRs-gene interaction network. Altogether, our data highlighted novel molecular mechanisms in the resolution of diabetes after bariatric surgery. Overall, diabetes resolution in our model appears to be totally independent of body weight
Spinelli, Valeria. "Les acides biliaires et la régulation de l’homéostasie métabolique : rôle du récepteur Farnesoid X Receptor (FXR) dans la cellule bêta-pancréatique : variation du pool des acides biliaires et chirurgie bariatrique Roux-en-Y Gastric Bypass". Thesis, Lille 2, 2015. http://www.theses.fr/2015LIL2S054.
Texto completoBile acids (BAs) are molecules produced in the liver, stored in the gallbladder, secreted into the intestine and returning to the liver via the enterohepatic circulation. A fraction of BAs escapes the reuptake by the liver and enters the systemic circulation, by which they reach the peripheral organs including the pancreas. Besides their function in facilitating the intestinal absorption of lipids, BAs are signaling molecules that act through receptors for BAs, which are expressed in the key tissues for metabolic regulation, and whose modulation by BAs contribute to regulate energy homeostasis. Thus, variations in the composition of the BAs pool determine the modulation of metabolism via their receptors. The BA-receptor Farnesoid-X receptor (FXR) is involved in the regulation of glucose, lipid and BA metabolism by its action in the liver, intestine, adipose tissue and pancreas. Whole body FXR deficient mice are glucose intolerant and insulin resistant in liver and peripheral tissues, whereas in a context of obesity, FXR deficiency rather improves these parameters. Furthermore, FXR is expressed in the pancreatic beta cell (bcell), where it regulates the synthesis and the secretion of insulin, but the molecular mechanisms have not been fully elucidated yet. To understand 1) the contribution of FXR bcell in the metabolic phenotype of the total FXRKO-mouse, and 2) the molecular mechanisms of the regulation of insulin production by FXR in the bcell, I developed a mouse model invalidated for FXR specifically in the bcell by the Cre-loxP strategy. The development of the model showed nonspecific recombination phenomena, and I developed a genotyping strategy to overcome this problem. To highlight the phenotype of the FXRKObcell mouse I tested various metabolic contexts (standard and high fat diet, fasting and refeeding conditions, circadian variations). Compared to control, FXRKO-bcell mice developed glucose intolerance and has lower insulinémia, defects increased by a high fat diet. The global transcriptomic analysis in the islets identified a set of microRNA strongly deregulated by invalidating FXR in the bcell, which could explain the dysfunctions in insulin secretion. Besides the modulation of the activity of the receptors, metabolic effects can be obtained by varying the composition of the pool of their ligands BAs. Thus, metabolic perturbations (such as insulin resistance and type 2 diabetes, obesity) are associated with qualitative and/or quantitative variations in the BA pool. In addition, variations of the BAs pool are associated to the metabolic improvement that precedes the weight loss after the surgical practice of Roux-en-Y Gastric Bypass (RYGB), which suggests that the BAs can be among the actors of the ‘weight loss-indipendent’ beneficial metabolic effects of RYGB. To investigate this hypothesis, some preclinical models of RYGB have been developed. During my thesis I compared the pool of BAs pre and post RYGB among three species (rat, pig and human; Coll. Prof. F. Pattou and Dr. E.Osto) with the aim of assessing which preclinical model is most suitable for these studies in terms of characteristics of the BAs pool. In a second study, I focused on the causes and mechanisms underlying the increased concentrations of circulating BAs induced by RYGB. In the model of minipig (coll. Pr. F. Pattou), the analysis of the plasma BA pool composition and the hepatic gene expression before and after RYGB, allowed to show that changes in the hepatic function are - at least in part - responsible for the increase of the BA pool following RYGB
Libros sobre el tema "Diabète – chirurgie"
Predine-Hug, François. L'odontologiste face à: Asthme, cirrhose, diabète, endocardite, épilepsie, grossesse, hémophilie, insuffisance cardiaque, AAP, AC, SIDA, toxicomanies : conduites à tenir. Paris: Éd. SID-Groupe EDP sciences, 2011.
Buscar texto completoCapítulos de libros sobre el tema "Diabète – chirurgie"
Largiadèr, F. "Chirurgie des Diabetes mellitus". En Pankreaschirurgie, 491–502. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-95476-4_23.
Texto completoPfaff, Daniel. "Fall 38: Bariatrische Chirurgie – 35 Jahre, ♀, Übergewicht, unerfüllter Kinderwunsch, Insulinresistenz". En Diabetes-Therapie – informiert entscheiden, 149–52. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-55972-7_38.
Texto completoQuabbe, H. J. "Risiko in der Chirurgie: Stoffwechselerkrankungen (Diabetes mellitus, Adipositas)". En Risiko in der Chirurgie, editado por R. Häring, 139–48. Berlin, Boston: De Gruyter, 1987. http://dx.doi.org/10.1515/9783110872002-020.
Texto completoHeberer, Michael y Bernulf Günther. "Diabetes mellitus". En Praxis der parenteralen und enteralen Ernährung in der Chirurgie, 188–93. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-71027-8_22.
Texto completoPfaff, Daniel. "Fall 44: Bariatrische Chirurgie – 58 Jahre, ♂, DM Typ 2, Sleeve-Gastrektomie". En Diabetes-Therapie – informiert entscheiden, 175–77. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-55972-7_44.
Texto completoAnger, Chr y Chr Puchstein. "Die Therapie des Diabetes mellitus in der perioperativen Phase". En Risiko in der Chirurgie, editado por R. Häring, 149–56. Berlin, Boston: De Gruyter, 1987. http://dx.doi.org/10.1515/9783110872002-021.
Texto completoHeiß, J. "Decubitus bei Angiopathie, Diabetes u. Intensivpflege". En Verhandlungen der Deutschen Gesellschaft für Chirurgie, 645–46. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-48161-1_259.
Texto completoPfaff, Daniel. "Fall 72: Bariatrische Chirurgie – 61 Jahre, ♂, DM Typ 2, Übergewicht, koronare Herzerkrankung, Albuminurie". En Diabetes-Therapie – informiert entscheiden, 289–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-55972-7_72.
Texto completoWiedemann, P. "Katarakt und Diabetes". En 12. Kongreß der Deutschsprachigen Gesellschaft für Intraokularlinsen-Implantation und refraktive Chirurgie, 317. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-60015-9_60.
Texto completoPfaff, Daniel. "Fall 45: Bariatrische Chirurgie – 63 Jahre, ♀, DM Typ 2, Übergewicht, Schlafstörung durch Muskelkrämpfe und Kribbeln". En Diabetes-Therapie – informiert entscheiden, 179–81. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-55972-7_45.
Texto completoActas de conferencias sobre el tema "Diabète – chirurgie"
Sandforth, Leontine, Erminia Lembo, Ornella Verrastro, Arvid Sandforth, Karin Zhou, Rami Archid, Robert Wagner et al. "Risikoclusterbasierte Vorteile bariatrischer Chirurgie für Menschen mit hohem Risiko für Diabetes mellitus Typ 2". En Diabetes Kongress 2023 - 57. Jahrestagung der DDG. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1767893.
Texto completoSandforth, Leontine, Violeta Raverdy, Arvid Sandforth, Pierre Bauvin, Marlene Ganslmeier, Estelle Chatelain, Robert Wagner et al. "Subphänotyp-abhängige Effekte bariatrischer Chirurgie in datengestützten Clustern von Menschen mit erhöhtem Risiko für Typ-2-Diabetes". En Diabetes. Umwelt. Leben. Perspektiven aus allen Blickwinkeln. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1785369.
Texto completoLaubner, Katharina, Angeliki Pappa, Anton Gillesen, Marcus Altmeier, Petra Augstein, Sebastian Meyhöfer, Julia K. Mader et al. "Bariatrische Chirurgie bei Menschen mit Diabetes mellitus Typ 1 oder 2 – eine multizentrische Analyse der DPV-Wiss-Datenbank". En Diabetes. Umwelt. Leben. Perspektiven aus allen Blickwinkeln. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1785344.
Texto completoKreyer, R., R. Otto, I. Gastinger, H. Lippert, R. S. Croner y F. Meyer. "Einfluss des Diabetes mellitus (DM) auf das frühpostoperative und Langzeit-onkochirurgische Outcome in der Colon-Karzinom(Ca)-Chirurgie (präliminäre Ergebnisse)". En Viszeralmedizin 2023 77. Jahrestagung der DGVS mit Sektion Endoskopie Herbsttagung der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie mit den Arbeitsgemeinschaften der DGAV und Jahrestagung der CACP. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1771938.
Texto completoKreyer, R., R. Otto, S. Wolff, I. Gastinger, H. Lippert, RS Croner y F. Meyer. "Frühpostoperatives und Langzeit-onkochirurgisches Outcome in der Colon-Karzinom (Ca)-Chirurgie in Abhängigkeit von einem manifesten Diabetes-mellitus (DM) - Interimsergebnisse". En DGVS Digital: BEST OF DGVS. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1716259.
Texto completoFrancois, Laura y Stephan Hackenberg. "Spontan aufgetretener Epiglottisabszess bei Erstdiagnose eines Diabetes mellitus". En 94. Jahresversammlung Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1766423.
Texto completoWittkowski, J., S. Strieth, C. Matthias y H. Gouveris. "Intratympanale Dexamethason/Hyaluronsäure und rheologische Infusionstherapie bei Diabetes mellitus Typ II – Patienten mit Hörsturz". En Abstract- und Posterband – 90. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Digitalisierung in der HNO-Heilkunde. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1686318.
Texto completoWittkowski, J., S. Strieth, C. Matthias y H. Gouveris. "Intratympanic and intravenous steroid therapy of idiopathic sudden sensorineural hearing loss in patients with and without diabetes mellitus". En Abstract- und Posterband – 90. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Digitalisierung in der HNO-Heilkunde. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1686547.
Texto completo